Physician profile
James Day
NPI 1225097488
$8,940.48
in general payments reported to CMS, 2019-2025
22 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,925 · 2020: $1,245 · 2021: $1,050 · 2022: $1,208 · 2023: $442 · 2024: $817 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,118.16 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,238.61 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Mc3 Tricuspid Annuloplasty Ring, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $1,232.86 | 2019-2022 | |
| Abiomed | $1,166.49 | 2021-2024 | Impella |
| Ethicon US, LLC | $327.73 | 2019-2021 | |
| Boston Scientific Corporation | $293.91 | 2019-2020 | |
| Getinge USA Sales, LLC | $262.91 | 2020-2024 | Vasoview Hemopro 2 |
| Zimmer Biomet Holdings, INC. | $236.02 | 2023-2024 | Sternalock Blu System, Sternalock |
| Medtronic, INC. | $147.83 | 2022-2023 | Corevalve Evolut R |
| Davol INC. | $145.97 | 2021 | |
| Terumo Cardiovascular Systems Corporation | $129.21 | 2020 | |
| Novartis Pharmaceuticals Corporation | $123.80 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.14 | 2019 | |
| Livanova USA, INC. | $91.54 | 2022 | |
| Depuy Synthes Sales INC. | $86.15 | 2025 | Matrixrib |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.89 | 2021-2025 | Lifevest |
| Abbott Laboratories | $65.67 | 2019-2025 | Navitor |
| Janssen Pharmaceuticals, INC | $24.60 | 2019 | |
| Cordis US Corp. | $19.10 | 2023 | Mynx Control |
| Cardiovascular Systems INC. | $19.10 | 2022 | |
| Bolton Medical INC | $15.08 | 2025 | Thoraflex Hybrid |
| Elutia, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.